Our team
AlphaNet Canada relies on a dedicated staff and Board of Directors who are committed to our mission of improving the lives of individuals affected by alpha-1 antitrypsin deficiency.
The AlphaNet team
AlphaNet Canada is governed by a Board of Directors chaired by Robert L. Greene, Jr. and operations are managed by Mark Delvaux, Chief Executive Officer.
Dr. Kenneth Chapman leads the organization’s medical direction in partnership with Dr. Robert Sandhaus.
Angela Diano, Executive Director, spearheads Canadian Alpha-1 advocacy efforts, working alongside Mike Benn, Program Manager, and the national team of AlphaNet Canada Coordinators.
For more information about our team of AlphaNet Coordinators, visit CONNECT WITH A COORDINATOR.